Search research articles
Contact Us
Filters
Showing results (91-100 of 119) with videos related to
Page
of 12
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
October 31, 2025
Total Body Irradiation Versus Chemotherapy-Only Conditioning in Autologous Haematopoietic Stem Cell Transplantation for Relapsed/Refractory Large B-cell Lymphoma
M Ebadi, X Fan, G Schoch, et al.
British Journal of Haematology
|
February 12, 2022
The impact of B-cell-directed therapy on SARS-CoV-2 vaccine efficacy in chronic lymphocytic leukaemia
Chaitra Ujjani, Mazyar Shadman, Ryan C Lynch, et al.
Cancer Research
|
September 4, 2016
Comparative Analysis of Bispecific Antibody and Streptavidin-Targeted Radioimmunotherapy for B-cell Cancers
Damian J Green, Shani L Frayo, Yukang Lin, et al.
British Journal of Haematology
|
May 3, 2019
Multicentre retrospective study of intravascular large B-cell lymphoma treated at academic institutions within the United States
Marcus Geer, Emily Roberts, Maryann Shango, et al.
Nature Communications
|
April 6, 2026
Influence of B cell-lineage targeted CAR-T cell therapy on humoral immunity and vaccine-induced antibody response
Stosh Ozog, Elizabeth M Krantz, Karyn Tindbaek, et al.
The Lancet. Haematology
|
July 30, 2021
Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study
Ryan C Lynch, Ryan D Cassaday, Stephen D Smith, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 23, 2013
Specific features identify patients with relapsed or refractory mantle cell lymphoma benefitting from autologous hematopoietic cell transplantation
Ryan D Cassaday, Katherine A Guthrie, Elizabeth L Budde, et al.
British Journal of Haematology
|
October 13, 2015
High-dose CD20-targeted radioimmunotherapy-based autologous transplantation improves outcomes for persistent mantle cell lymphoma
Ryan D Cassaday, Philip A Stevenson, Theodore A Gooley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 9, 2015
Maintenance rituximab after autologous stem cell transplantation in patients with mantle cell lymphoma
S A Graf, P A Stevenson, L A Holmberg, et al.
The Lancet. Oncology
|
July 6, 2023
γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial
Andrew J Cowan, Margot J Pont, Blythe D Sather, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 119) with videos related to
Sort By:
Page
of 12
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
October 31, 2025
Total Body Irradiation Versus Chemotherapy-Only Conditioning in Autologous Haematopoietic Stem Cell Transplantation for Relapsed/Refractory Large B-cell Lymphoma
M Ebadi, X Fan, G Schoch, et al.
British Journal of Haematology
|
February 12, 2022
The impact of B-cell-directed therapy on SARS-CoV-2 vaccine efficacy in chronic lymphocytic leukaemia
Chaitra Ujjani, Mazyar Shadman, Ryan C Lynch, et al.
Cancer Research
|
September 4, 2016
Comparative Analysis of Bispecific Antibody and Streptavidin-Targeted Radioimmunotherapy for B-cell Cancers
Damian J Green, Shani L Frayo, Yukang Lin, et al.
British Journal of Haematology
|
May 3, 2019
Multicentre retrospective study of intravascular large B-cell lymphoma treated at academic institutions within the United States
Marcus Geer, Emily Roberts, Maryann Shango, et al.
Nature Communications
|
April 6, 2026
Influence of B cell-lineage targeted CAR-T cell therapy on humoral immunity and vaccine-induced antibody response
Stosh Ozog, Elizabeth M Krantz, Karyn Tindbaek, et al.
The Lancet. Haematology
|
July 30, 2021
Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study
Ryan C Lynch, Ryan D Cassaday, Stephen D Smith, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 23, 2013
Specific features identify patients with relapsed or refractory mantle cell lymphoma benefitting from autologous hematopoietic cell transplantation
Ryan D Cassaday, Katherine A Guthrie, Elizabeth L Budde, et al.
British Journal of Haematology
|
October 13, 2015
High-dose CD20-targeted radioimmunotherapy-based autologous transplantation improves outcomes for persistent mantle cell lymphoma
Ryan D Cassaday, Philip A Stevenson, Theodore A Gooley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 9, 2015
Maintenance rituximab after autologous stem cell transplantation in patients with mantle cell lymphoma
S A Graf, P A Stevenson, L A Holmberg, et al.
The Lancet. Oncology
|
July 6, 2023
γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial
Andrew J Cowan, Margot J Pont, Blythe D Sather, et al.
Page
of 12